Evidence map›Paper›PMID 36499630›Full record

ArticleInternational journal of molecular sciences2022

ATPase Inhibitory Factor 1-A Novel Marker of Cellular Fitness and Exercise Capacity?

Remigiusz Domin, Michał Pytka, Jan Niziński, Mikołaj Żołyński, Ariadna Zybek-Kocik, Elżbieta Wrotkowska, Jacek Zieliński, Przemysław Guzik, Marek Ruchała

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Ucp1 Ablation Improves Skeletal Muscle Glycolytic Function in Aging Mice.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Remigiusz DominDepartment of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, 60-355 Poznan, Poland.ORCID 0000-0002-5190-4056
Michał PytkaUniversity Centre for Sport and Medical Studies, Poznan University of Medical Sciences, 60-802 Poznan, Poland.ORCID 0000-0002-8418-0090
Jan NizińskiUniversity Centre for Sport and Medical Studies, Poznan University of Medical Sciences, 60-802 Poznan, Poland.ORCID 0000-0002-5455-3845
Mikołaj ŻołyńskiUniversity Centre for Sport and Medical Studies, Poznan University of Medical Sciences, 60-802 Poznan, Poland.ORCID 0000-0003-1334-9466
Ariadna Zybek-KocikDepartment of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, 60-355 Poznan, Poland.
Elżbieta WrotkowskaDepartment of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, 60-355 Poznan, Poland.
Jacek ZielińskiDepartment of Athletics, Strength and Conditioning, Poznan University of Physical Education, 61-871 Poznan, Poland.ORCID 0000-0002-2782-9973
Przemysław GuzikUniversity Centre for Sport and Medical Studies, Poznan University of Medical Sciences, 60-802 Poznan, Poland.ORCID 0000-0001-9052-5027
Marek RuchałaDepartment of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, 60-355 Poznan, Poland.ORCID 0000-0002-6296-7220
Poznan University of Medical Sciences · PL

Funding

Poznan University of Medical Sciences 502-14-12213550-45006The Ministry of Education and Science, Warsaw, Poland NdS/544750/2021/2022
6 · The paper itself

Abstract

ATPase inhibitory factor 1 is a myokine inhibiting the hydrolytic activity of mitochondrial adenosine triphosphate synthase and ecto-F1-ATPase on the surface of many cells. IF1 affects ATP metabolism in mitochondria and the extracellular space and upregulates glucose uptake in myocytes; these processes are essential in physical activity. It is unknown whether the IF1 serum concentration is associated with exercise capacity. This study explored the association between resting IF1 serum concentration and exercise capacity indices in healthy people. IF1 serum concentration was measured in samples collected at rest in 97 healthy amateur cyclists. Exercise capacity was assessed on a bike ergometer at the successive stages of the progressive cardiopulmonary exercise test (CPET). IF1 serum concentration was negatively and significantly correlated with oxygen consumption, oxygen pulse, and load at various CPET stages. A better exercise capacity was associated with lower circulating IF1. IF1 may reflect better cellular/mitochondrial energetic fitness, but there is uncertainty regarding how IF1 is released into the intravascular space. We speculate that lower IF1 concentration may reflect a better cellular/mitochondrial integrity, as this protein is bound more strongly with ATPases in mitochondria and cellular surfaces in people with higher exercise capacity.

Indexed as

Exercise ToleranceProton-Translocating ATPasesAdenosine TriphosphateATPase Inhibitory ProteinExerciseHumansMitochondrial ProteinsProteinsAdenosine TriphosphateATPase Inhibitory ProteinMitochondrial ProteinsProteinsProton-Translocating ATPasesexercise capacityexercise-induced cytokineIF1inhibitory factor 1myokine

Identifiers

PMID36499630
PMCPMC9741029
OpenAlexW4310675693

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.